Effects of melatonin ( mélatonine )on cardiovascular diseases: progress in the past year.
Curr Opin Lipidol. 2016 Apr 12;
Authors: Sun H, Gusdon AM, Qu S
Abstract
PURPOSE OF REVIEW: Melatonin is a neuroendocrine hormone synthesized primarily by the pineal gland. Numerous studies have suggested that melatonin ( mélatonine )plays an important role in various cardiovascular diseases. In this article, recent progress regarding melatonin's effects on cardiovascular diseases is reviewed.
RECENT FINDINGS: In the past year, studies have focused on the mechanism of protection of melatonin ( mélatonine )on cardiovascular diseases, including myocardial ischemia-reperfusion injury, myocardial hypoxia-reoxygenation injury, pulmonary hypertension, hypertension, atherosclerosis, valvular heart diseases, and other cardiovascular diseases.
SUMMARY: Studies have demonstrated that melatonin ( mélatonine )has significant effects on ischemia-reperfusion injury, myocardial chronic intermittent hypoxia injury, pulmonary hypertension, hypertension, valvular heart diseases, vascular diseases, and lipid metabolism. As an inexpensive and well tolerated drug, melatonin ( mélatonine )may be a new therapeutic option for cardiovascular disease.
PMID: 27075419 [PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/27075419?dopt=Abstract